Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Criteo (CRTO) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Criteo (CRTO) over the last 15 years, with Q2 2025 value amounting to $205.7 million.

  • Criteo's Cash & Equivalents fell 507.39% to $205.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $205.7 million, marking a year-over-year decrease of 507.39%. This contributed to the annual value of $290.7 million for FY2024, which is 1357.19% down from last year.
  • Latest data reveals that Criteo reported Cash & Equivalents of $205.7 million as of Q2 2025, which was down 507.39% from $285.8 million recorded in Q1 2025.
  • In the past 5 years, Criteo's Cash & Equivalents ranged from a high of $589.3 million in Q1 2022 and a low of $194.9 million during Q3 2023
  • For the 5-year period, Criteo's Cash & Equivalents averaged around $353.6 million, with its median value being $306.5 million (2022).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 1914.15% in 2021, then plummeted by 6032.63% in 2023.
  • Over the past 5 years, Criteo's Cash & Equivalents (Quarter) stood at $515.5 million in 2021, then plummeted by 32.46% to $348.2 million in 2022, then dropped by 3.41% to $336.3 million in 2023, then dropped by 13.57% to $290.7 million in 2024, then decreased by 29.24% to $205.7 million in 2025.
  • Its Cash & Equivalents stands at $205.7 million for Q2 2025, versus $285.8 million for Q1 2025 and $290.7 million for Q4 2024.